Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma

BACKGROUND: Preclinical studies suggest that chemotherapy may enhance the immune response against pancreatic cancer. METHODS: The levels of granulocyte macrophage-colony-stimulating factor (GM-CSF) and interleukin-6 (IL-6) and the associated inflammatory marker C-reactive protein (CRP) were assessed...

Descripción completa

Detalles Bibliográficos
Autores principales: Middleton, Gary, Greenhalf, William, Costello, Eithne, Shaw, Victoria, Cox, Trevor, Ghaneh, Paula, Palmer, Daniel H, Neoptolemos, John P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782200/
https://www.ncbi.nlm.nih.gov/pubmed/26931369
http://dx.doi.org/10.1038/bjc.2015.468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782200/
https://www.ncbi.nlm.nih.gov/pubmed/26931369
http://dx.doi.org/10.1038/bjc.2015.468

Ejemplares similares